The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Serum uric acid levels and the risk of Parkinson disease
Abstract
In a prospective population‐based cohort study among 4,695 participants aged 55 years and older, with repeated in‐person examination and on average 9.4 years of follow‐up, we observed that higher serum levels of uric acid were associated with a significantly decreased risk of Parkinson disease (adjusted hazard ratio per standard deviation increase 0.71 [95% confidence interval 0.51–0.98]), with evidence for a dose–effect relationship (p value for trend over quartiles 0.040). Our findings support the hypothesis that oxidative stress contributes to the risk of Parkinson disease and suggest a potential protective effect of the natural antioxidant and free radical scavenger uric acid. Ann Neurol 2005;58:797–800
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6858 · Cited by 2,909
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Recent Developments in Parkinson's Disease
Hurtig, H. I. (1987) · Neurology · doi:10.1212/wnl.37.5.893 · Cited by 1,920
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
Determinants of disease and disability in the elderly: The Rotterdam elderly study
Hofman, A., Grobbee, D. E., De Jong, P. T. V. M., & Van den Ouweland, F. A. (1991) · European Journal of Epidemiology · doi:10.1007/bf00145007 · Cited by 1,129
Self-citationChoi, H. K., Liu, S., & Curhan, G. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20761 · Cited by 595
Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid
Davies, K. J. A., Sevanian, A., Muakkassah-Kelly, S. F., & Hochstein, P. (1986) · Biochemical Journal · doi:10.1042/bj2350747 · Cited by 558
Emmerson, B. T. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602153340707 · Cited by 516
Duan, W., Ladenheim, B., Cutler, R. G., Kruman, I. I., Cadet, J. L., & Mattson, M. P. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00676.x · Cited by 405
Incidence of parkinsonism and Parkinson disease in a general population: The Rotterdam Study
de Lau, L. M. L., Giesbergen, P. C. L. M., de Rijk, M. C., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2004) · Neurology · doi:10.1212/01.wnl.0000140706.52798.be · Cited by 360
Self-citationYu, Z. F., Bruce-Keller, A. J., Goodman, Y., & Mattson, M. P. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980901)53:5<613::aid-jnr11>3.0.co;2-1 · Cited by 359
Smoking, nicotine and Parkinson's disease
Quik, M. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.06.008 · Cited by 324
Observations on Serum Uric Acid Levels and the Risk of Idiopathic Parkinson's Disease
Davis, J. W., Grandinetti, A., Waslien, C. J., Ross, G. W., White, L. R., & Morens, D. M. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008954 · Cited by 216
Hink, H. U., Santanam, N., Dikalov, S., McCann, L., Nguyen, A. D., Parthasarathy, S., Harrison, D. G., & Fukai, T. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000027524.86752.02 · Cited by 202
Uric acid is reduced in the substantia nigra in parkinson's disease: Effect on dopamine oxidation
Church, W. H., & Ward, V. L. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90285-2 · Cited by 173
Diet and Parkinson's disease: A potential role of dairy products in men
Chen, H., Zhang, S. M., Hernán, M. Á., Willett, W. C., & Ascherio, A. (2002) · Annals of Neurology · doi:10.1002/ana.10381 · Cited by 166
New enzymatic method for serum uric acid at 500 nm.
Trivedi, R. C., Rebar, L., Berta, E., & Stong, L. J. (1978) · Clinical Chemistry · doi:10.1093/clinchem/24.11.1908 · Cited by 148
Obesity and the Risk of Parkinson's Disease
Chen, H., Zhang, S. M., Schwarzschild, M. A., Hernán, M. A., Willett, W. C., & Ascherio, A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh059 · Cited by 132
Alcohol consumption and the incidence of Parkinson's disease
Hernán, M. Á., Chen, H., Schwarzschild, M. A., & Ascherio, A. (2003) · Annals of Neurology · doi:10.1002/ana.10611 · Cited by 87
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease
Fitzmaurice, P. S., Ang, L. C., Guttman, M., Rajput, A. H., Furukawa, Y., & Kish, S. J. (2003) · Movement Disorders · doi:10.1002/mds.10486 · Cited by 81
Cited by
The epidemiology of Parkinson's disease: risk factors and prevention
Ascherio, A., & Schwarzschild, M. A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30230-7 · Cited by 1,825
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Parkinson’s Disease in Women and Men: What’s the Difference?
Cerri, S., Mus, L., & Blandini, F. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191683 · Cited by 800
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
Bogdanov, M., Matson, W. R., Wang, L., Matson, T., Saunders-Pullman, R., Bressman, S. S., & Beal, M. F. (2008) · Brain · doi:10.1093/brain/awm304 · Cited by 401
Plasma Urate and Risk of Parkinson's Disease
Weisskopf, M., O'Reilly, E., Chen, H., Schwarzschild, M., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm127 · Cited by 390
Metadata
- Authors
- de Lau, L. M. L., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2005-10-20
- Volume
- 58
- Issue
- 5
- Pages
- 797-800
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2121816670
- Cited by
- 301
- References
- 21
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.